STX6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.556000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.228800E-01
Normal-vs-Stage2
9.122200E-01
Normal-vs-Stage3
3.860000E-01
Normal-vs-Stage4
4.511600E-01
Stage1-vs-Stage2
1.670640E-01
Stage1-vs-Stage3
7.704200E-01
Stage1-vs-Stage4
1.197170E-01
Stage2-vs-Stage3
1.319970E-01
Stage2-vs-Stage4
2.475800E-01
Stage3-vs-Stage4
1.526410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.708000E-01
Normal-vs-AfricanAmerican
3.004600E-01
Normal-vs-Asian
6.463000E-01
Caucasian-vs-AfricanAmerican
3.160300E-02
Caucasian-vs-Asian
1.764570E-01
AfricanAmerican-vs-Asian
8.757800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.528800E-01
Normal-vs-Female
9.610400E-01
Male-vs-Female
9.709000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.420200E-01
Normal-vs-Age(41-60Yrs)
7.661000E-01
Normal-vs-Age(61-80Yrs)
8.112400E-01
Normal-vs-Age(81-100Yrs)
8.106600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.429990E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.237600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.471180E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.780000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.359000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.974200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.639800E-01
Normal-vs-Daily Drinker
5.277200E-01
Normal-vs-Weekly Drinker
9.227600E-01
Normal-vs-Occasional Drinker
7.071600E-01
Normal-vs-Social Drinker
9.278600E-01
Non Drinker-vs-Daily Drinker
2.573000E-01
Non Drinker-vs-Weekly Drinker
7.863400E-01
Non Drinker-vs-Occasional Drinker
4.291600E-01
Non Drinker-vs-Social Drinker
9.570400E-01
Daily Drinker-vs-Weekly Drinker
2.272400E-01
Daily Drinker-vs-Occasional Drinker
5.952200E-02
Daily Drinker-vs-Social Drinker
2.989600E-01
Weekly Drinker-vs-Occasional Drinker
6.893600E-01
Weekly Drinker-vs-Social Drinker
7.564800E-01
Occasional Drinker-vs-Social Drinker
4.006800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.126600E-01
Normal-vs-Grade 2
5.118400E-03
Normal-vs-Grade 3
5.042500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.569090E-04
Grade 1-vs-Grade 3
1.223850E-04
Grade 1-vs-Grade 4
2.126600E-01
Grade 2-vs-Grade 3
2.726800E-01
Grade 2-vs-Grade 4
5.118400E-03
Grade 3-vs-Grade 4
5.042500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.541600E-01
Normal-vs-NonDiabetic
9.611600E-01
Diabetic-vs-NonDiabetic
1.170980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.886000E-01
Normal-vs-NoPancreatitis
9.395600E-01
Pancreatitis-vs-NoPancreatitis
5.495800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.255600E-01
Normal-vs-N1
9.508400E-01
N0-vs-N1
3.408000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.542000E-01
Normal-vs-TP53-NonMutant
7.454400E-01
TP53-Mutant-vs-TP53-NonMutant
3.456500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
